News & Regulatory Updates

Stay informed about the latest regulatory requirements, industry developments, and expert insights from MedNet EC-REP

Updated regularly
32 Articles
London Eye
Regulatory Updates

UK Updates Post-Market Surveillance Requirements for Medical Devices

The Medicines and Healthcare products Regulatory Agency (MHRA) has released updated guidance on post-market surveillance (PMS) requirements for medical devices in Great Britain. The document, titled "The Medical Devices Post-Market Surveillance Requirements (Amendment) Great Britain Regulations 2024: Guidance on Implementation," provides clarification and details on fulfilling the regulatory obligations for manufacturers.

MedNet EC-REP
Read more
Switzerland Flag in the Mountains
Regulatory Updates

Swissmedic Highlights Post-Market Surveillance Obligations for Legacy Devices

Swissmedic, the Swiss Agency for Therapeutic Products, has released findings from a recent focused action, underscoring the critical importance of robust Post-Market Surveillance (PMS) for all medical devices, including those classified as Legacy Devices (LDs). The review emphasizes that manufacturers must actively monitor the performance and safety of their devices throughout their lifecycle.

MedNet EC-REP
Read more
European Parlament
Regulatory Updates

EU Commission Updates Guidance on SARS-CoV-2 Test Classification

The In Vitro Diagnostic (IVD) expert panel of the European Commission has released new scientific advice regarding SARS-CoV-2. The panel notes that, while the virus can still cause serious illness, it no longer poses a life-threatening risk with a significant mortality rate for the general European population.

MedNet EC-REP
Read more
EAR
Regulatory Updates

EU Initiative on Medical Devices and In-Vitro Diagnostics: A Targeted Evaluation

The European Commission has launched a public consultation as part of its targeted evaluation of the EU rules on medical devices and in-vitro diagnostics. This initiative is focused on assessing the effectiveness, efficiency, relevance, and coherence of the current regulations. It aims to ensure that the regulatory framework continues to support innovation, public health, and safety in the rapidly evolving medical technology sector.

MedNet EC-REP
Read more
Brussel EU Parlament
Regulatory Updates

EU Publishes Second Revision of MDCG 2023-3: Key Updates for Manufacturers

The European Commission has released the second revision of the MDCG 2023-3 guidance document in January 2025. This update includes important clarifications in line with Regulation (EU) 2024/1860, affecting the implementation of Eudamed, post-market surveillance, and reporting timelines. Below, we summarize the key changes:

MedNet EC-REP
Read more
EU Parlament
Regulatory Updates

Key Changes in MDCG 2022-4 Rev 2 for Medical Device Manufacturers

The European Commission has issued the revised MDCG 2022-4 guidance, focusing on appropriate surveillance during the transition from the Medical Devices Directive (MDD) and Active Implantable Medical Devices Directive (AIMDD) to the Medical Device Regulation (MDR).

MedNet EC-REP
Read more
MDR
Regulatory Updates

Deadline Alert: Submission Requirements for MDR Conformity Assessment

We're pleased to provide you with important updates regarding the extended transition period for certain medical devices under Regulation (EU) 2023/607. As the landscape of medical device regulations continues to evolve, it's crucial for stakeholders to remain informed and compliant.

MedNet EC-REP
Read more